Nucleolin interacts with the dengue virus capsid protein and plays a role in formation of infectious virus particles

Journal of Virology

Volumn 87, Issue 24, 2013, Pages 13094-13106

  Balinsky, Corey A ^a   Schmeisser, Hana ^a   Ganesan, Sundar ^a   Singh, Kavita ^a   Pierson, Theodore C ^a   Zoon, Kathryn C ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; NUCLEOLIN; SMALL INTERFERING RNA; VIRUS RNA;

ARTICLE; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; GENE SILENCING; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; VIROGENESIS; VIRUS LOAD; VIRUS MORPHOGENESIS; VIRUS PARTICLE;

CAPSID PROTEINS; DENGUE; DENGUE VIRUS; HEK293 CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; PHOSPHOPROTEINS; PROTEIN BINDING; PROTEIN TRANSPORT; RNA-BINDING PROTEINS; VIRUS RELEASE; VIRUS REPLICATION;

EID: 84888026992     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00704-13     Document Type: Article

References (85)

1. WHO. 2006. Scientific working group report on dengue. WHO reference number TDR/SWG/08. WHO, Geneva, Switzerland.
2. Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ, Hunsperger E, Kroeger A, Margolis HS, Martínez E, Nathan MB, Pelegrino JL, Simmons C, Yoksan S, Peeling RW. 2010. Dengue:a continuing global threat. Nat. Rev. Microbiol. 8:S7-S16.
3. Kyle JL, Harris E. 2008. Global spread and persistence of dengue. Annu. Rev. Microbiol. 62:71-92.
4. Perera R, Kuhn RJ. 2008. Structural proteomics of dengue virus. Curr. Opin. Microbiol. 11:369-377.
5. Rodenhuis-Zybert IA, Wilschut J, Smit JM. 2010. Dengue virus life cycle:viral and host factors modulating infectivity. Cell. Mol. Life Sci. 67:2773-2786.
6. Jones CT, Ma L, Burgner JW, Groesch TD, Post CB, Kuhn RJ. 2003. Flavivirus capsid is a dimeric alpha-helical protein. J. Virol. 77:7143-7149.
7. Ma L, Jones CT, Groesch TD, Kuhn RJ, Post CB. 2004. Solution structure of dengue virus capsid protein reveals another fold. Proc. Natl. Acad. Sci. U.S.A. 101:3414-3419.
8. Khromykh AA, Varnavski AN, Sedlak PL, Westaway EG. 2001. Coupling between replication and packaging of flavivirus RNA:evidence derived from the use of DNA-based full-length cDNA clones of Kunjin virus. J. Virol. 75:4633-4640.
9. Ivanyi-Nagy R, Darlix J-L. 2012. Core protein-mediated 5'-3' annealing of the West Nile virus genomic RNA in vitro. Virus Res. 167:226-235.
10. Tseng H-N, Lee C-C, Wong M-L, Chen S-O, Liu J-J. 2007. DNA-binding property of recombinant capsid protein of Japanese encephalitis virus. Virus Genes 35:483-488.
11. López C, Gil L, Lazo L, Menéndez I, Marcos E, Sánchez J, Valdés I, Falcón V, De la Rosa MC, Márquez G, Guillén G, Hermida L. 2009. In vitro assembly of nucleocapsid-like particles from purified recombinant capsid protein of dengue-2 virus. Arch. Virol. 154:695-698.
12. Patkar CG, Jones CT, Chang Y, Warrier R, Kuhn RJ. 2007. Functional requirements of the yellow fever virus capsid protein. J. Virol. 81:6471-6481.
13. Samsa MM, Mondotte JA, Caramelo JJ, Gamarnik AV. 2012. Uncoupling cis-acting RNA elements from coding sequences revealed a requirement of the N-terminal region of dengue virus capsid protein in virus particle formation. J. Virol. 86:1046-1058.
14. Schrauf S, Mandl CW, Bell-Sakyi L, Skern T. 2009. Extension of flavivirus protein C differentially affects early RNA synthesis and growth in mammalian and arthropod host cells. J. Virol. 83:11201-11210.
15. Peña J, Harris E. 2012. Early dengue virus protein synthesis induces extensive rearrangement of the endoplasmic reticulum independent of the UPR and SREBP-2 pathway. PLoS One 7:e38202. doi:10.1371/journal.pone.0038202.
16. Gillespie LK, Hoenen A, Morgan G, Mackenzie JM. 2010. The endoplasmic reticulum provides the membrane platform for biogenesis of the flavivirus replication complex. J. Virol. 84:10438-10447.
17. Mackenzie JM, Westaway EG. 2001. Assembly and maturation of the flavivirus Kunjin virus appear to occur in the rough endoplasmic reticulum and along the secretory pathway, respectively. J. Virol. 75:10787-10799.
18. Carvalho FA, Carneiro FA, Martins IC, Assunção-Miranda I, Faustino AF, Pereira RM, Bozza PT, Castanho MARB, Mohana-Borges R, Da Poian AT, Santos NC. 2012. Dengue virus capsid protein binding to hepatic lipid droplets (LD) is potassium ion dependent and is mediated by LD surface proteins. J. Virol. 86:2096-2108.
19. Samsa MM, Mondotte JA, Iglesias NG, Assunção-Miranda I, Barbosa-Lima G, Da Poian AT, Bozza PT, Gamarnik AV. 2009. Dengue virus capsid protein usurps lipid droplets for viral particle formation. PLoS Pathog. 5:e1000632. doi:10.1371/journal.ppat.1000632.
20. Martins IC, Gomes-Neto F, Faustino AF, Carvalho FA, Carneiro FA, Bozza PT, Mohana-Borges R, Castanho MARB, Almeida FCL, Santos NC, Da Poian AT. 2012. The disordered N-terminal region of dengue virus capsid protein contains a lipid-droplet-binding motif. Biochem. J. 444:405-415.
21. Byrd CM, Dai D, Grosenbach DW, Berhanu A, Jones KF, Cardwell KB, Schneider C, Wineinger KA, Page JM, Harver C, Stavale E, Tyavanagimatt S, Stone MA, Bartenschlager R, Scaturro P, Hruby DE, Jordan R. 2013. A novel inhibitor of dengue virus replication that targets the capsid protein. Antimicrob. Agents Chemother. 57:15-25.
22. Bulich R, Aaskov JG. 1992. Nuclear localization of dengue 2 virus core protein detected with monoclonal antibodies. J. Gen. Virol. 73:2999-3003.
23. Sangiambut S, Keelapang P, Aaskov J, Puttikhunt C, Kasinrerk W, Malasit P, Sittisombut N. 2008. Multiple regions in dengue virus capsid protein contribute to nuclear localization during virus infection. J. Gen. Virol. 89:1254-1264.
24. Wang S-H, Syu W-J, Huang K-J, Lei H-Y, Yao C-W, King C-C, Hu S-T. 2002. Intracellular localization and determination of a nuclear localization signal of the core protein of dengue virus. J. Gen. Virol. 83:3093-3102.
25. Pong W-L, Huang Z-S, Teoh P-G, Wang C-C, Wu H-N. 2011. RNA binding property and RNA chaperone activity of dengue virus core protein and other viral RNA-interacting proteins. FEBS Lett. 585:2575-2581.
26. Limjindaporn T, Netsawang J, Noisakran S, Thiemmeca S, Wongwiwat W, Sudsaward S, Avirutnan P, Puttikhunt C, Kasinrerk W, Sriburi R, Sittisombut N, Yenchitsomanus P-T, Malasit P. 2007. Sensitization to Fas-mediated apoptosis by dengue virus capsid protein. Biochem. Biophys. Res. Commun. 362:334-339.
27. Netsawang J, Noisakran S, Puttikhunt C, Kasinrerk W, Wongwiwat W, Malasit P, Yenchitsomanus P, Limjindaporn T. 2010. Nuclear localization of dengue virus capsid protein is required for DAXX interaction and apoptosis. Virus Res. 147:275-283.
28. Chang CJ, Luh HW, Wang SH, Lin HJ, Lee SC, Hu ST. 2001. The heterogeneous nuclear ribonucleoprotein K (hnRNP K) interacts with dengue virus core protein. DNA Cell Biol. 20:569-577.
29. Colpitts TM, Barthel S, Wang P, Fikrig E. 2011. Dengue virus capsid protein binds core histones and inhibits nucleosome formation in human liver cells. PLoS One 6:e24365. doi:10.1371/journal.pone.0024365.
30. Li J, Huang R, Liao W, Chen Z, Zhang S, Huang R. 2012. Dengue virus utilizes calcium modulating cyclophilin-binding ligand to subvert apoptosis. Biochem. Biophys. Res. Commun. 418:622-627.
31. Mongelard F, Bouvet P. 2007. Nucleolin:a multiFACeTed protein. Trends Cell Biol. 17:80-86.
32. Tajrishi MM, Tuteja R, Tuteja N. 2011. Nucleolin:the most abundant multifunctional phosphoprotein of nucleolus. Commun. Integr. Biol. 4:267-275.
33. Lo SJ, Lee C-C, Lai H-J. 2006. The nucleolus:reviewing oldies to have new understandings. Cell Res. 16:530-538.
34. Abdelmohsen K, Gorospe M. 2012. RNA-binding protein nucleolin in disease. RNA Biol. 9:799-808.
35. Mongelard F, Bouvet P. 2010. AS-1411, a guanosine-rich oligonucleotide aptamer targeting nucleolin for the potential treatment of cancer, including acute myeloid leukemia. Curr. Opin. Mol. Ther. 12:107-114.
36. Soundararajan S, Wang L, Sridharan V, Chen W, Courtenay-Luck N, Jones D, Spicer EK, Fernandes DJ. 2009. Plasma membrane nucleolin is a receptor for the anticancer aptamer AS1411 in MV4-11 leukemia cells. Mol. Pharmacol. 76:984-991.
37. Krust B, El Khoury D, Soundaramourty C, Nondier I, Hovanessian AG. 2011. Suppression of tumorigenicity of rhabdoid tumor derived G401 cells by the multivalent HB-19 pseudopeptide that targets surface nucleolin. Biochimie 93:426-433.
38. Destouches D, Page N, Hamma-Kourbali Y, Machi V, Chaloin O, Frechault S, Birmpas C, Katsoris P, Beyrath J, Albanese P, Maurer M, Carpentier G, Strub J-M, Van Dorsselaer A, Muller S, Bagnard D, Briand JP, Courty J. 2011. A simple approach to cancer therapy afforded by multivalent pseudopeptides that target cell-surface nucleoproteins. Cancer Res. 71:3296-3305.
39. Zhuo W, Luo C, Wang X, Song X, Fu Y, Luo Y. 2010. Endostatin inhibits tumour lymphangiogenesis and lymphatic metastasis via cell surface nucleolin on lymphangiogenic endothelial cells. J. Pathol. 222:249-260.
40. Shi H, Huang Y, Zhou H, Song X, Yuan S, Fu Y, Luo Y. 2007. Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin. Blood 110:2899-2906.
41. Hovanessian AG. 2006. Midkine, a cytokine that inhibits HIV infection by binding to the cell surface expressed nucleolin. Cell Res. 16:174-181.
42. Said EA, Courty J, Svab J, Delbé J, Krust B, Hovanessian AG. 2005. Pleiotrophin inhibits HIV infection by binding the cell surface-expressed nucleolin. FEBS J. 272:4646-4659.
43. Nisole S, Krust B, Callebaut C, Guichard G, Muller S, Briand JP, Hovanessian AG. 1999. The anti-HIV pseudopeptide HB-19 forms a complex with the cell-surface-expressed nucleolin independent of heparan sulfate proteoglycans. J. Biol. Chem. 274:27875-27884.
44. Bose S, Basu M, Banerjee AK. 2004. Role of nucleolin in human parainfluenza virus type 3 infection of human lung epithelial cells. J. Virol. 78:8146-8158.
45. Tayyari F, Marchant D, Moraes TJ, Duan W, Mastrangelo P, Hegele RG. 2011. Identification of nucleolin as a cellular receptor for human respiratory syncytial virus. Nat. Med. 17:1132-1135.
46. Xiao X, Feng Y, Zhu Z, Dimitrov DS. 2011. Identification of a putative Crimean-Congo hemorrhagic fever virus entry factor. Biochem. Biophys. Res. Commun. 411:253-258.
47. Thongtan T, Wikan N, Wintachai P, Rattanarungsan C, Srisomsap C, Cheepsunthorn P, Smith DR. 2012. Characterization of putative Japanese encephalitis virus receptor molecules on microglial cells. J. Med. Virol. 84:615-623.
48. Izumi RE, Valdez B, Banerjee R, Srivastava M, Dasgupta A. 2001. Nucleolin stimulates viral internal ribosome entry site-mediated translation. Virus Res. 76:17-29.
49. Greco A, Arata L, Soler E, Gaume X, Couté Y, Hacot S, Callé A, Monier K, Epstein AL, Sanchez J-C, Bouvet P, Diaz J-J. 2012. Nucleolin interacts with US11 protein of herpes simplex virus 1 and is involved in its trafficking. J. Virol. 86:1449-1457.
50. Sagou K, Uema M, Kawaguchi Y. 2010. Nucleolin is required for efficient nuclear egress of herpes simplex virus type 1 nucleocapsids. J. Virol. 84:2110-2121.
51. Ueno T, Tokunaga K, Sawa H, Maeda M, Chiba J, Kojima A, Hasegawa H, Shoya Y, Sata T, Kurata T, Takahashi H. 2004. Nucleolin and the packaging signal, psi, promote the budding of human immunodeficiency virus type-1 (HIV-1). Microbiol. Immunol. 48:111-118.
52. Shimakami T, Honda M, Kusakawa T, Murata T, Shimotohno K, Kaneko S, Murakami S. 2006. Effect of hepatitis C virus (HCV) NS5Bnucleolin interaction on HCV replication with HCV subgenomic replicon. J. Virol. 80:3332-3340.
53. Hiscox JA. 2002. The nucleolus-a gateway to viral infection? Arch. Virol. 147:1077-1089.
54. Melén K, Tynell J, Fagerlund R, Roussel P, Hermandez-Verdun D, Julkunen I. 2012. Influenza A H3N2 subtype virus NS1 protein targets into the nucleus and binds primarily via its C-terminal NLS2/NoLS to nucleolin and fibrillarin. Virol. J. 9:167.
55. Jiang Y, Li Z, Nagy PD. 2010. Nucleolin/Nsr1p binds to the 3' noncoding region of the tombusvirus RNA and inhibits replication. Virology 396:10-20.
56. Cancio-Lonches C, Yocupicio-Monroy M, Sandoval-Jaime C, Galvan-Mendoza I, Ureña L, Vashist S, Goodfellow I, Salas-Benito J, Gutiérrez-Escolano AL. 2011. Nucleolin interacts with the feline calicivirus 3' untranslated region and the protease-polymerase NS6 and NS7 proteins, playing a role in virus replication. J. Virol. 85:8056-8068.
57. Waggoner S, Sarnow P. 1998. Viral ribonucleoprotein complex formation and nucleolar-cytoplasmic relocalization of nucleolin in poliovirusinfected cells. J. Virol. 72:6699-6709.
58. Gubler DJ, Reed D, Rosen L, Hitchcock JR, Jr. 1978. Epidemiologic, clinical, and virologic observations on dengue in the Kingdom of Tonga. Am. J. Trop. Med. Hyg. 27:581-589.
59. Blaney JE, Jr, Hanson CT, Hanley KA, Murphy BR, Whitehead SS. 2004. Vaccine candidates derived from a novel infectious cDNA clone of an American genotype dengue virus type 2. BMC Infect. Dis. 4:39.
60. Schmeisser H, Mejido J, Balinsky CA, Morrow AN, Clark CR, Zhao T, Zoon KC. 2010. Identification of alpha interferon-induced genes associated with antiviral activity in Daudi cells and characterization of IFIT3 as a novel antiviral gene. J. Virol. 84:10671-10680.
61. Schneider CA, Rasband WS, Eliceiri KW. 2012. NIH Image to ImageJ:25 years of image analysis. Nat. Methods 9:671-675.
62. Ganesan S, Rohde G, Eckermann K, Sroka K, Schaefer MKE, Dohm CP, Kermer P, Haase G, Wouters F, Bähr M, Weishaupt JH. 2008. Mutant SOD1 detoxification mechanisms in intact single cells. Cell Death Differ. 15:312-321.
63. Ireson CR, Kelland LR. 2006. Discovery and development of anticancer aptamers. Mol. Cancer Ther. 5:2957-2962.
64. Reyes-Reyes EM, Teng Y, Bates PJ. 2010. A new paradigm for aptamer therapeutic AS1411 action:uptake by macropinocytosis and its stimulation by a nucleolin-dependent mechanism. Cancer Res. 70:8617-8629.
65. Singh K, Gitti RK, Diouf A, Zhou H, Gowda DC, Miura K, Ostazeski SA, Fairhurst RM, Garboczi DN, Long CA. 2010. Subdomain 3 of Plasmodium falciparum VAR2CSA DBL3x is identified as a minimal chondroitin sulfate A-binding region. J. Biol. Chem. 285:24855-24862.
66. Schmeisser H, Gorshkova I, Brown PH, Kontsek P, Schuck P, Zoon KC. 2007. Two interferons alpha influence each other during their interaction with the extracellular domain of human type interferon receptor subunit 2. Biochemistry 46:14638-14649.
67. Schreiber E, Matthias P, Müller MM, Schaffner W. 1989. Rapid detection of octamer binding proteins with "mini-extracts", prepared from a small number of cells. Nucleic Acids Res. 17:6419.
68. Polacek C, Friebe P, Harris E. 2009. Poly(A)-binding protein binds to the non-polyadenylated 3' untranslated region of dengue virus and modulates translation efficiency. J. Gen. Virol. 90:687-692.
69. Dapić V, Bates PJ, Trent JO, Rodger A, Thomas SD, Miller DM. 2002. Antiproliferative activity of G-quartet-forming oligonucleotides with backbone and sugar modifications. Biochemistry 41:3676-3685.
70. Dapić V, Abdomerović V, Marrington R, Peberdy J, Rodger A, Trent JO, Bates PJ. 2003. Biophysical and biological properties of quadruplex oligodeoxyribonucleotides. Nucleic Acids Res. 31:2097-2107.
71. Bates PJ, Kahlon JB, Thomas SD, Trent JO, Miller DM. 1999. Antiproliferative activity of G-rich oligonucleotides correlates with protein binding. J. Biol. Chem. 274:26369-26377.
72. Bates PJ, Laber DA, Miller DM, Thomas SD, Trent JO. 2009. Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer. Exp. Mol. Pathol. 86:151-164.
73. Nagy PD, Pogany J. 2012. The dependence of viral RNA replication on co-opted host factors. Nat. Rev. Microbiol. 10:137-149.
74. Pastorino B, Nougairède A, Wurtz N, Gould E, De Lamballerie X. 2010. Role of host cell factors in flavivirus infection:implications for pathogenesis and development of antiviral drugs. Antiviral Res. 87:281-294.
75. Paranjape SM, Harris E. 2010. Control of dengue virus translation and replication. Curr. Top. Microbiol. Immunol. 338:15-34.
76. Konishi E, Fujii A. 2002. Dengue type 2 virus subviral extracellular particles produced by a stably transfected mammalian cell line and their evaluation for a subunit vaccine. Vaccine 20:1058-1067.
77. Wang P-G, Kudelko M, Lo J, Siu LYL, Kwok KTH, Sachse M, Nicholls JM, Bruzzone R, Altmeyer RM, Nal B. 2009. Efficient assembly and secretion of recombinant subviral particles of the four dengue serotypes using native prM and E proteins. PLoS One 4:e8325. doi:10.1371/journal.pone.0008325.
78. Zhu W, Qin C, Chen S, Jiang T, Yu M, Yu X, Qin E. 2007. Attenuated dengue 2 viruses with deletions in capsid protein derived from an infectious full-length cDNA clone. Virus Res. 126:226-232.
79. Kofler RM, Heinz FX, Mandl CW. 2002. Capsid protein C of tick-borne encephalitis virus tolerates large internal deletions and is a favorable target for attenuation of virulence. J. Virol. 76:3534-3543.
80. Schlick P, Kofler RM, Schittl B, Taucher C, Nagy E, Meinke A, Mandl CW. 2010. Characterization of West Nile virus live vaccine candidates attenuated by capsid deletion mutations. Vaccine 28:5903-5909.
81. Schlick P, Taucher C, Schittl B, Tran JL, Kofler RM, Schueler W, Von Gabain A, Meinke A, Mandl CW. 2009. Helices alpha2 and alpha3 of West Nile virus capsid protein are dispensable for assembly of infectious virions. J. Virol. 83:5581-5591.
82. Groat-Carmona AM, Orozco S, Friebe P, Payne A, Kramer L, Harris E. 2012. A novel coding-region RNA element modulates infectious dengue virus particle production in both mammalian and mosquito cells and regulates viral replication in Aedes aegypti mosquitoes. Virology 432:511-526.
83. Martín-Acebes MA, Blázquez A-B, De Oya NJ, Escribano-Romero E, Shi P-Y, Saiz J-C. 2013. A single amino acid substitution in the core protein of West Nile virus increases resistance to acidotropic compounds. PLoS One 8:e69479. doi:10.1371/journal.pone.0069479.
84. Makino Y, Tadano M, Anzai T, Ma SP, Yasuda S, Fukunaga T. 1989. Detection of dengue 4 virus core protein in the nucleus. II. Antibody against dengue 4 core protein produced by a recombinant baculovirus reacts with the antigen in the nucleus. J. Gen. Virol. 70:1417-1425.
85. Mori Y, Okabayashi T, Yamashita T, Zhao Z, Wakita T, Yasui K, Hasebe F, Tadano M, Konishi E, Moriishi K, Matsuura Y. 2005. Nuclear localization of Japanese encephalitis virus core protein enhances viral replication. J. Virol. 79:3448-3458.